FDA rejects Novo Nordisk insulin remedy - FDA rejects Novo Nordisk insulin remedy Shares in Danish drugmaker fall 13%, wiping DKr80bn from its market value, as US watchdog requests further tests into potential heart risks Source: Pharmaceuticals companies news from the Financial Times Psychology, Special Needs & Health.